MetLife/$MET
1D1W1MYTD1Y5YMAX
Capital at risk
About MetLife
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
- Ticker
- $MET
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 46,000
- Headquarters
- New York, United States
- Website
- www.metlife.com
MetLife Metrics
BasicAdvanced
$62B
18.62
$5.22
0.76
$2.32
2.44%
Price and volume
Market cap
$62B
Beta
0.76
52-week high
$100.93
52-week low
$67.33
Average daily volume
3.2M
Dividend rate
$2.32
Financial strength
Current ratio
2.027
Quick ratio
3.98
Long term debt to equity
96.459
Total debt to equity
179.933
Dividend payout ratio (TTM)
46.36%
Interest coverage (TTM)
4.83%
Profitability
EBITDA (TTM)
6,040
Gross margin (TTM)
23.95%
Net profit margin (TTM)
4.57%
Operating margin (TTM)
6.64%
Effective tax rate (TTM)
24.85%
Revenue per employee (TTM)
$1,730,000
Management effectiveness
Return on assets (TTM)
0.45%
Return on equity (TTM)
13.09%
Valuation
Price to earnings (TTM)
18.62
Price to revenue (TTM)
0.801
Price to book
2.26
Price to tangible book (TTM)
3.46
Price to free cash flow (TTM)
4.131
Free cash flow yield (TTM)
24.21%
Free cash flow per share (TTM)
23.514
Dividend yield (TTM)
2.39%
Forward dividend yield
2.44%
Growth
Revenue change (TTM)
8.74%
Earnings per share change (TTM)
-11.97%
3-year revenue growth (CAGR)
4.34%
10-year revenue growth (CAGR)
1.67%
3-year earnings per share growth (CAGR)
10.55%
10-year earnings per share growth (CAGR)
3.20%
3-year dividend per share growth (CAGR)
4.35%
10-year dividend per share growth (CAGR)
4.17%
What the Analysts think about MetLife
Analyst ratings (Buy, Hold, Sell) for MetLife stock.
Analyst projections of the future price of MetLife stock.
Bulls say / Bears say
In Q2 2026, MetLife’s adjusted earnings rose 15% to $1.6 billion, driven by favorable underwriting and broad volume growth across all segments; Group Benefits profit surged 25% and Asia earnings climbed 21%. (Reuters)
MetLife’s robust capital position is underscored by a 2025 combined NAIC Risk-Based Capital ratio of 379%, well above its 360% target, supporting AA-/Aa3/AA- ratings from S&P, Moody’s, and Fitch with stable outlooks. (Fortune)
MetLife’s board approved a new $3.0 billion share repurchase authorization in August 2026, reflecting management’s confidence in its cash flow generation and long-term value creation. (Reuters)
MetLife’s Retirement and Income Solutions segment saw adjusted earnings increase just 2% in Q2 2026, highlighting margin pressure from recurring interest spreads in its largest U.S. business. (SEC)
MetLife’s net investment income, buoyed by elevated interest rates, jumped 18% to $6.7 billion in Q2, but this dependency creates earnings volatility should rates decline. (Reuters)
With approximately 25% of adjusted earnings coming from its Asia segment—largely concentrated in Japan—MetLife faces margin risk as the BoJ, after leaving rates at 1%, signals possible rate hikes. (Axios)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2026.
MetLife Financial Performance
Revenues and expenses
MetLife Earnings Performance
Company profitability
Upcoming events
No upcoming events
MetLife News
AllArticlesVideos
Funds containing MetLife
AllEURUSDGBP
Fund name | Fund size | $MET weighting |
|---|---|---|
iShares Dow Jones U.S. Select Dividend€EXX5 | €412M | 1.31% |
iShares S&P 500 Financials Sector$IUFS | $2.4B | 0.65% |
iShares S&P 500 Financials Sector£UIFS | £1.8B | 0.65% |
iShares Ageing Population€AGED | €822M | 0.54% |
L&G Global Quality Dividends£LDGG | £279M | 0.24% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.